BRIEF-Paysign, Inc. Announces Acquisition of Gamma Innovation's Assets, Appoints Michael Ngo as Chief Innovation Officer-February 2024-www.financetom.com

BRIEF-Paysign, Inc. Announces Acquisition of Gamma Innovation's Assets, Appoints Michael Ngo as Chief Innovation Officer

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Paysign, Inc. Announces Acquisition of Gamma Innovation's Assets, Appoints Michael Ngo as Chief Innovation Officer

Mar 25, 2025 5:38 AM

March 25 (Reuters) - Paysign Inc ( PAYS ):

* PAYSIGN, INC. ( PAYS ) ANNOUNCES ACQUISITION OF GAMMA INNOVATION'S

ASSETS, APPOINTS MICHAEL NGO AS CHIEF INNOVATION OFFICER

Source text:

Further company coverage:

Previous page： Oil Falls For Second Day As Israel-Gaza Ceasefire Eases Geopolitical Risk Next page： Legacy Housing Names Co-Founder Kenny Shipley Interim CEO; Ron Arrington Interim CFO

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Oil Falls For Second Day As Israel-Gaza Ceasefire Eases Geopolitical Risk

Oct 10, 2025

08:50 AM EDT, 10/10/2025 (MT Newswires) -- Oil prices eased early Friday, extending losses for a second day as traders priced in lower geopolitical risk following a U.S.-backed ceasefire in Israel's war on Gaza. West Texas Intermediate crude oil for November delivery was last seen down US$0.95 to $60.56 per barrel, while December Brent oil was down $0.97 to $64.25....

Legacy Housing Names Co-Founder Kenny Shipley Interim CEO; Ron Arrington Interim CFO

Oct 10, 2025

08:48 AM EDT, 10/10/2025 (MT Newswires) -- Legacy Housing ( LEGH ) said Friday it appointed co-founder and chairman Kenny Shipley as interim chief executive officer, succeeding the prior CEO Robert Duncan Bates following his resignation. The board also named company veteran Ron Arrington interim chief financial officer, succeeding the outgoing finance chief as part of the same transition, the...

Bristol-Myers Squibb to Acquire Orbital Therapeutics in $1.5 Billion Deal

Oct 10, 2025

08:55 AM EDT, 10/10/2025 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) on Friday agreed to acquire privately-held ribonucleic acid medication manufacturer Orbital Therapeutics in an all-cash deal worth about $1.5 billion, as it aims to boost its cell therapy portfolio. The transaction is expected to give Bristol Myers access to Orbital's lead pre-clinical candidate for chimeric antigen receptor T-cell...

Sector Update: Consumer

Oct 10, 2025

08:53 AM EDT, 10/10/2025 (MT Newswires) -- Consumer stocks were steady pre-bell Friday, with the Consumer Staples Select Sector SPDR Fund (XLP) up a slight 0.1% and the Consumer Discretionary Select Sector SPDR Fund (XLY) unchanged. Levi Strauss (LEVI) shares were down more than 7% even after the company posted higher fiscal Q3 adjusted earnings and net revenue that beat...